Cargando…

Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort

OBJECTIVE: This study aimed to compare cause‐specific mortality rates in patients with type 2 diabetes with and without various vascular complications. METHODS: In Japanese hospitals, we followed up 30 834 patients with a mean age of 64.4 (standard deviation [SD]: 11.1) years. Patients were followed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokomichi, Hiroshi, Nagai, Akiko, Hirata, Makoto, Mochizuki, Mie, Kojima, Reiji, Yamagata, Zentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831228/
https://www.ncbi.nlm.nih.gov/pubmed/33532618
http://dx.doi.org/10.1002/edm2.181
_version_ 1783641592563761152
author Yokomichi, Hiroshi
Nagai, Akiko
Hirata, Makoto
Mochizuki, Mie
Kojima, Reiji
Yamagata, Zentaro
author_facet Yokomichi, Hiroshi
Nagai, Akiko
Hirata, Makoto
Mochizuki, Mie
Kojima, Reiji
Yamagata, Zentaro
author_sort Yokomichi, Hiroshi
collection PubMed
description OBJECTIVE: This study aimed to compare cause‐specific mortality rates in patients with type 2 diabetes with and without various vascular complications. METHODS: In Japanese hospitals, we followed up 30 834 patients with a mean age of 64.4 (standard deviation [SD]: 11.1) years. Patients were followed up from 2003 to 2007 for a median of 7.5 (interquartile range: 6.1‐9.7) years. We calculated cause‐specific mortality rates (number of deaths/1000 person‐years) and confounder‐adjusted hazard ratios in patients with macrovascular disease and in those with diabetic nephropathy, neuropathy and retinopathy, allowing for overlap of complications. RESULTS: All‐cause mortality rate was highest (51.4) in the nephropathy group, followed by the macrovascular disease group (45.2), the neuropathy group (39.5), the retinopathy group (38.7) and the nonvascular complication group (18.1). In the nephropathy group, morality rates of ischaemic heart, cerebrovascular, and infectious diseases and cancer were also highest among the groups. However, the cancer mortality rate was similar among the vascular complication groups. Relative to the nonvascular complication group, covariate‐adjusted hazard ratios for ischaemic heart and cerebrovascular disease mortality were triple to quadruple in the macro‐ and microvascular complication groups. All‐cause mortality rates rose exponentially according to age. CONCLUSION: Highest risks of all‐cause, cancer, and ischaemic heart, infectious, and cerebrovascular disease mortality were determined in Japanese patients with diabetic nephropathy. Although cancer is the primary cause of death in Japanese patients with diabetes, cancer mortality rates are similar among those with and without vascular complications.
format Online
Article
Text
id pubmed-7831228
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78312282021-02-01 Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort Yokomichi, Hiroshi Nagai, Akiko Hirata, Makoto Mochizuki, Mie Kojima, Reiji Yamagata, Zentaro Endocrinol Diabetes Metab Original Research Articles OBJECTIVE: This study aimed to compare cause‐specific mortality rates in patients with type 2 diabetes with and without various vascular complications. METHODS: In Japanese hospitals, we followed up 30 834 patients with a mean age of 64.4 (standard deviation [SD]: 11.1) years. Patients were followed up from 2003 to 2007 for a median of 7.5 (interquartile range: 6.1‐9.7) years. We calculated cause‐specific mortality rates (number of deaths/1000 person‐years) and confounder‐adjusted hazard ratios in patients with macrovascular disease and in those with diabetic nephropathy, neuropathy and retinopathy, allowing for overlap of complications. RESULTS: All‐cause mortality rate was highest (51.4) in the nephropathy group, followed by the macrovascular disease group (45.2), the neuropathy group (39.5), the retinopathy group (38.7) and the nonvascular complication group (18.1). In the nephropathy group, morality rates of ischaemic heart, cerebrovascular, and infectious diseases and cancer were also highest among the groups. However, the cancer mortality rate was similar among the vascular complication groups. Relative to the nonvascular complication group, covariate‐adjusted hazard ratios for ischaemic heart and cerebrovascular disease mortality were triple to quadruple in the macro‐ and microvascular complication groups. All‐cause mortality rates rose exponentially according to age. CONCLUSION: Highest risks of all‐cause, cancer, and ischaemic heart, infectious, and cerebrovascular disease mortality were determined in Japanese patients with diabetic nephropathy. Although cancer is the primary cause of death in Japanese patients with diabetes, cancer mortality rates are similar among those with and without vascular complications. John Wiley and Sons Inc. 2020-08-27 /pmc/articles/PMC7831228/ /pubmed/33532618 http://dx.doi.org/10.1002/edm2.181 Text en © 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Articles
Yokomichi, Hiroshi
Nagai, Akiko
Hirata, Makoto
Mochizuki, Mie
Kojima, Reiji
Yamagata, Zentaro
Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
title Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
title_full Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
title_fullStr Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
title_full_unstemmed Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
title_short Cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: BioBank Japan Cohort
title_sort cause‐specific mortality rates in patients with diabetes according to comorbid macro‐ and microvascular complications: biobank japan cohort
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831228/
https://www.ncbi.nlm.nih.gov/pubmed/33532618
http://dx.doi.org/10.1002/edm2.181
work_keys_str_mv AT yokomichihiroshi causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort
AT nagaiakiko causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort
AT hiratamakoto causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort
AT mochizukimie causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort
AT kojimareiji causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort
AT yamagatazentaro causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort
AT causespecificmortalityratesinpatientswithdiabetesaccordingtocomorbidmacroandmicrovascularcomplicationsbiobankjapancohort